Form 4: USANA Health Sciences Inc: Officer Peter Benedict Reports Stock Transactions
SEC Form 4 Filing
Peter Benedict, Chief Information Officer of USANA Health Sciences Inc, reports transactions involving common stock and restricted stock units on February 8, 2025.
Summary
- On February 8, 2025, Peter Benedict, the Chief Information Officer of USANA Health Sciences Inc., engaged in transactions involving the company's common stock and restricted stock units.
- Benedict disposed of 229 shares of common stock at a price of $30.65.
- He also disposed of 401 shares of common stock at a price of $30.65.
- He acquired 658 shares of common stock through the vesting of restricted stock units.
- He acquired 1,157 shares of common stock through the vesting of restricted stock units.
- Following these transactions, Benedict directly owns 2,251 shares of common stock.
- He also holds 9,651 restricted stock units that vest 25% annually from February 8, 2021, and 8,494 restricted stock units that vest 25% annually from February 8, 2024.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It simply reports transactions and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for officers of publicly traded companies, providing transparency into their stock transactions. It doesn't necessarily reflect broader industry trends but offers insight into individual executive compensation and stock ownership.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies like USANA, similar to filings made by executives at Herbalife Nutrition, Nu Skin Enterprises, and other companies in the nutritional supplement industry.
- The vesting schedules for restricted stock units (RSUs) are common compensation tools used across the industry to align executive incentives with long-term company performance.
- The specific amounts and vesting terms of RSUs can vary significantly between companies based on factors such as company size, executive role, and overall compensation strategy.
Stakeholder Impact
- The transactions reported in this filing may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
- The vesting of restricted stock units incentivizes the officer to contribute to the company's success, potentially benefiting all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 02/08/2021 | Initial vesting date for 25% of 9,651 Restricted Stock Units |
| 02/08/2024 | Initial vesting date for 25% of 8,494 Restricted Stock Units |
| 02/08/2025 | Date of reported transactions: stock disposal and vesting of restricted stock units. |
| 02/11/2025 | Date of filing the Form 4. |
Keywords
USANA Health Sciences Inc, Peter Benedict, Stock Transactions, Restricted Stock Units, Form 4, USNA, Officer, Chief Information Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.